Endometrial cancer, one of the most common gynecological malignancies worldwide, has been quietly rising in incidence for decades, and for patients whose disease advances or recurs, the therapeutic landscape remains frustratingly thin. Now, a team of researchers at The First Affiliated Hospital of Zhengzhou University in China has identified a molecular driver of this aggressiveness […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.